GIC-backed Asia Healthcare Holdings to acquire Dr Dangs Labs
:
Asia Healthcare Holdings (AHH), backed by Singapore's sovereign wealth fund GIC, is set to acquire a majority stake in Dr Dangs Labs, a diagnostic chain operating in Delhi and Gurugram, according to two people aware of the development.
This marks the fourth acquisition by AHH, following previous deals with Motherhood Hospitals, the Asian Institute of Nephrology and Urology (AINU), and Nova IVF.
Details of the financial terms of the deal were not disclosed.
Read this |
Singles are hot: Why private equity firms are increasingly investing in these hospitals
AHH's earlier investment in AINU in 2023, valued at
₹
600 crore, involved both primary and secondary funding. AHH has also seen significant capital inflows, including a $150 million investment from GIC in December 2024, which made the sovereign fund the largest shareholder in the company. GIC had also invested $170 million in AHH in February 2022.
Before GIC's additional investment, AHH was majority-owned by global private equity firm TPG, which now holds a minority stake in the platform. The GIC investment likely valued AHH at $800-900 million,
Mint
reported earlier.
With plans to eventually go public, AHH is gearing up for an initial public offering (IPO), although no timeline has been provided. According to Vishal Bali, executive chairman of AHH, profitability is not a concern as the company moves towards its listing, which is expected within the next few years.
Dr Dangs Labs operates seven centres across Delhi and Gurugram and reported a revenue of
₹
67.7 crore for the financial year ended 31 March 2024, according to Tracxn.
Read this |
Jashvik Capital to acquire over 50% stake in Smart Vision Eye Hospitals
Bali has reportedly said that AHH is growing at 25% year-on-year and aims to reach nearly
₹
6,000 crore in revenue by FY32.
AHH declined to comment on the acquisition, and Dr Dangs Labs did not respond to an email request for information at the time of publication.
India's healthcare and diagnostics sector has seen a sharp uptick in private equity investments and mergers and acquisitions (M&A) in recent years. According to a report by Grant Thornton Bharat and the Association of Healthcare Providers of India (AHPI), India's healthcare and pharma sector recorded 594 transactions valued at over $30 billion between 2022 and 2024. Foreign direct investment (FDI) in the sector also rose, totalling $3.2 billion during the same period.
Also read |
India's fragmented hospital sector ripe for consolidation: Rothchild's Hollamby
In recent months, there have been notable deals within the diagnostics space. Neuberg Diagnostics raised
₹
9,400 million from Kotak Alt in January 2025, marking the largest primary fund-raise in Indian diagnostics and the company's first private equity round.
Meanwhile, Temasek Holdings and Oswal Alternates jointly invested approximately $85 million in Molbio Diagnostics in 2024, and Fortis Healthcare increased its stake in Agilus Diagnostics from 57% to 91% by acquiring a 34% stake from private equity firms Jacob Ballas and IFC.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
10 minutes ago
- Economic Times
IndiGo stands ready to resume flights to China: CEO Pieter Elbers
IndiGo CEO Pieter Elbers announced the airline's readiness to resume direct flights between India and China, which were suspended due to the coronavirus pandemic in early 2020. Prior to the suspension, IndiGo operated daily flights from Delhi to Chengdu and Kolkata to Guangzhou. Negotiations between India and China are reportedly in an advanced stage to re-establish these direct air services. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads New Delhi: IndiGo CEO Pieter Elbers on Wednesday said the airline stands ready to resume direct flights between India and Tuesday, people familiar with the matter said India and China are in an "advanced stage" of negotiations to resume direct flights between the two countries said IndiGo operated daily flights between India and China prior to the coronavirus pandemic."The airline stands ready to resume these services as soon as bilateral arrangements between the two countries allow," he said in a statement on also said that guided by its entrepreneurial spirit, the airline remains committed to identifying and pursuing commercially viable was operating daily flights from Delhi to Chengdu till February 6, 2020, and from Kolkata to Guangzhou till February 1, flights were operational between the two countries till early 2020 before getting suspended due to the coronavirus pandemic. Both Indian and Chinese carriers had direct services remained suspended in view of the eastern Ladakh border India also had flights from Delhi to Shanghai, and those were also suspended in early January 27 this year, India and China in principle agreed to resume direct air services between the two countries as part of certain people-centric steps to "stabilise and rebuild" the bilateral ties.
Economic Times
25 minutes ago
- Economic Times
EAM Jaishankar to visit Russia next week
Synopsis S Jaishankar's upcoming Russia visit aims to strengthen strategic ties in key economic areas. This occurs amid a planned Trump-Putin meeting in Alaska, potentially impacting the Russia-Ukraine war and US tariffs on Indian goods. Discussions between Jaishankar and Lavrov are expected to address the meeting's outcomes, with a possible Arctic region visit also on the agenda. ANI
Time of India
26 minutes ago
- Time of India
ET Make in India SME Regional Summits: How Lahori Zeera stormed India's beverage aisles
Live Events Product: It has to be genuinely good, something people crave. Price: 'South Bombay and South Delhi are not India,' Munjal noted. 'Out of 145 crore people, only 10 crore file income tax returns, and half of those pay zero. Our brand is built for the other 135 crore.' Distribution: If the product and price are right, retailers will welcome it. It started, quite literally, in the ordinary day, three cousins sat together. Not with a business plan, but with the simple urge to build something — anything. Then, one cousin wandered into the kitchen, made a concoction, and served it. The first sip of that concoction became their 'Eureka!' case you're wondering, it was a jeera drink. And that drink became the spark for Lahori Zeera , the cult favourite 'chatpata' beverage that holds its own in India's cutthroat soft drink market.'It's something so basic, yet so deeply part of our culture,' recalled Saurabh Munjal, Co-Founder and CEO of Archian Foods Pvt Ltd , the company behind Lahori Zeera. 'But we thought 'why not make this commercial?''Munjal headlined the business success story fireside chat at the ET Make in India SME Regional Summit in Chandigarh, which took place on August 7. IDBI was the banking and lending partner, and Canon was the tech enabler for the of Lahori Zeera's early days, Munjal added that he couldn't help but compare India's limited beverages with the dizzying variety in supermarkets abroad. 'Even in Tier-I Indian cities, the options were sparse,' he said. 'We knew this was the right space to enter.'From day one, Lahori Zeera set out to be more than a drink: it would be a statement of Indianness. When Munjal pitched the idea to his father after returning from Singapore, the reaction was blunt: 'You want to compete with Coke and Pepsi? Are you crazy?'It was a daunting challenge, but it taught the team some important first was that India is not one market. Saurabh calls it the 'United States of India', where languages, cultures, and taste profiles change every 100 km. Even a simple vegetable dish tastes different in every state. And so the brand had to adapt to local preferences, one region at a second lesson was that local flavours matter. India is unusual in how Coke and Pepsi dominate; in many countries, half the market belongs to local beverages, Munjal pointed third lesson was that there's no one-size-fits-all formula. Success meant going deep and understanding districts, cities, and states the ET SME Summit - Chandigarh, Munjal also shared that Lahori Zeera's rise didn't depend on Blinkit, Swiggy Instamart, or other quick commerce players. 'In beverages, 70% of sales, even for Coke and Pepsi, come from local kiranas,' he said. For Lahori Zeera, general trade contributes 98% of commerce has its place in dense urban pockets, but for most of India, the corner shop remains king. 'Both will coexist. But kirana stores are still the backbone,' he into the FMCG sector equals fighting for shelf space, and incumbents don't give it up easily. In impulse-buy categories like Lahori Zeera's, you might get someone to try your drink once through marketing or fancy packaging. But if it's not good, they won't buy Lahori Zeera, three pillars were non-negotiable:And when it comes to startup valuations, Munjal believes there should be more to them than revenue. The founder, potential scale, and size of the category all matter; a small category caps growth quickly, but a large one offers room to scale. But profitability counts above all. If it's not profitable, you're doing something wrong, he to the Archian Foods CEO, we are living in India's golden era, a rare moment when capital, talent, infrastructure, and policy are all aligned. He also offered crucial advice for young entrepreneurs in Punjab: to dream, desire, and do. Many people dream and desire, but never act:'Your kids will one day ask, 'when India was having its moment, what were you doing?' My suggestion is to stop overthinking and start doing. The path won't be easy, but you'll find your way.'Today, Lahori Zeera is sold in 15 Indian states and proudly headquartered in Chandigarh, with no plans to shift base. The brand aims to go pan-India soon, and achieve an international presence within five ultimate goal? 'To be the preferred beverage brand in India,' Munjal concluded without hesitation at the ET Make in India SME Regional Summit - the brand's journey from a kitchen experiment to a large-scale player, that dream doesn't sound ET Make in India SME Regional Summits, ET MSME Day, and ET MSME Awards are flagship initiatives to celebrate the versatility and success of India's MSME sector. If you lead or are part of a micro, small, or medium enterprise, register for the ET MSME Awards 2025 before August 31, 2025.
